Dr Reddys proposal for emergency use approval of Olokizumab for Covid-19 rejected by CDSCO panel MD Bureau2 Feb 2021 2:29 PM GMTNew Delhi: In a setback to Dr Reddy's Laboratories Limited, the Central Drugs Standard Control Organization (CDSCO) committee has rejected its...
Drug majors including Cipla, Sun Pharma, Pfizer, others owe Rs 6,550 crore overcharged amount : NPPA Farhat Nasim29 Jan 2021 1:14 PM GMTNew Delhi: Several drug majors including Cipla, Ranbaxy, Lupin, Glenmark, Sun Pharma have been accused of overcharging consumers to the tune of...
All Covid-19 vaccines to be stored at 2-8 degrees Celsius: Dept of Biotechnology Ruchika Sharma6 Jan 2021 7:40 AM GMTNew Delhi: All Indian vaccines being developed against the coronavirus can be stored at 2-8 degrees Celsius as the logistics have been worked out...
Setback to Dr Reddys: CDSCO panel rejects proposal to test Covid vaccine Sputnik-V due to inadequate data Ruchika Sharma8 Oct 2020 10:36 AM GMTThe recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from...
Dr Reddys launches OTC eye allergy drop Olopatadine Hydrochloride Ophthalmic Solution in US Ruchika Sharma18 Sep 2020 6:07 AM GMTThe Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% is also indicated for the temporary relief of red eyes.
PIL against 10 top pharma Cos in SC alleging sale of Remdesivir and Favipiravir without valid license Ruchika Sharma7 Sep 2020 7:56 AM GMTIt has also made 10 pharmaceutical companies, including Cipla Ltd, Dr Reddy's Laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd,...
Dr Reddys Labs: USFDA closes warning letter for three sites Ruchika Sharma30 Aug 2020 4:45 AM GMTIn November 2015, Dr Reddy's had said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites --...
FY21: Dr Reddy's Q1 results to be released on July 29th Ruchika Sharma22 July 2020 4:00 AM GMTHyderabad: Dr Reddy's Laboratories Ltd. has recently said that the company will announce results for the first quarter ended June 30, 2020, on...
Dr Reddy's New drugs for pediatrics, dermatology, oncology on the anvil Farhat Nasim25 Jun 2020 7:16 AM GMTThe products' segment focuses on research and development, and commercialization of different formulations.
CDSCO reviewing Cipla, Dr Reddys, others applications for Remdesivir on priority: Health Ministry Ruchika Sharma15 Jun 2020 10:30 AM GMTThe CDSCO is awaiting the data and is providing complete support to these companies. It has already waived off the requirement of local clinical...
Dr Reddy's Labs gets USFDA nod for ELYXYB(celecoxib oral solution) for migraine Ruchika Sharma7 May 2020 8:24 AM GMTHyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the approval of ELYXYB (celecoxib oral solution 25 mg/mL) by the U.S. Food and...
India Ratings and Research assigns A1-plus rating to Dr Reddy's commercial papers Ruchika Sharma4 May 2020 7:44 AM GMTMumbai: India Ratings and Research (Ind-Ra) has accorded AA-plus rating to Dr Reddy's Laboratories Ltd's (DRL's) long-term issuer rating with stable...
